CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis
Open Access
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 205 (1-2) , 165-167
Abstract
No abstract availableKeywords
Funding Information
- Stockholm County Council and the Karolinska Institutet, the Swedish Research Council (K2007-62X-15078-04-3, K2008-62P-20597-01-3, K2009-61P-21304-04-4, K2009-61X-21305-01-1)
- Wallenberg Foundation and the HUBIN project
This publication has 12 references indexed in Scilit:
- CSF biomarkers in suicide attempters – a principal component analysisActa Psychiatrica Scandinavica, 2010
- Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With SchizophreniaSchizophrenia Bulletin, 2010
- Suicide in schizophreniaExpert Review of Neurotherapeutics, 2010
- Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolitesActa Neuropsychiatrica, 2007
- Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophreniaSchizophrenia Research, 2005
- The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological ImplicationsThe Journal of Neuroscience, 2001
- The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of SchizophreniaNeuropsychopharmacology, 1999
- Neurotransmitters and Suicidal BehaviorAnnals of the New York Academy of Sciences, 1997
- Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sitesBrain Research, 1989
- Aberrant Monoamine Metabolite Levels in CSF and Family History of SchizophreniaArchives of General Psychiatry, 1980